Cutaneous sporotrichosis of face: polymorphism and reactivation after intralesional triamcinolone.
Cutaneous sporotrichosis, a subcutaneous mycotic infection is caused by the saprophytic, dimorphic fungus Sporothrix schenckii. It commonly presents as lymphocutaneous or fixed cutaneous lesions involving the upper extremities with facial lesions being seen more often in children. The lesions are polymorphic. The therapeutic response to saturated solution of potassium iodide is almost diagnostic. We describe a culture-proven case of cutaneous sporotrichosis of the face mimicking lupus vulgaris initially and basal cell carcinoma later, who did not tolerate potassium iodide and failed to respond to treatment with fluconazole. The patient had reactivation of infection following an infiltration of the scar with triamcinolone acetonide injection. Various other aspects of these unusual phenomena are also discussed.
Sharma
Nand Lal
NL
Department of Dermatology, Venereology and Leprosy, Indira Gandhi Medical College, Shimla, India. nandlals@hotmail.com
Mehta
Karan Inder Singh
KI
Mahajan
Vikram K
VK
Kanga
Anil K
AK
Sharma
Vikas Chander
VC
Tegta
Gita R
GR
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000935:Antifungal Agents / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D005151:Facial Injuries / Q000150:complications*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D013174:Sporotrichosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D014221:Triamcinolone / Q000008:administration & dosage / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D014221:Triamcinolone